U.S. Transportation Stock News

NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Is It Too Late To Consider Baker Hughes (BKR) After Its Strong 1 Year Share Price Rally?

If you are wondering whether Baker Hughes at around US$64.72 is starting to look expensive or if there is still value on the table, this article will walk you through what the numbers are really saying about the stock. The share price has recently been strong, with returns of 8.1% over the last 7 days, 20.0% over 30 days, 37.3% year to date and 49.9% over 1 year, while the 3 year return is 126.5% and the 5 year return is 200.4%. Recent news coverage has focused on Baker Hughes as a major...
NasdaqGM:SIBN
NasdaqGM:SIBNMedical Equipment

SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...
NYSE:GTY
NYSE:GTYRetail REITs

A Look At Getty Realty (GTY) Valuation After Completing Its US$129.92 Million Follow On Equity Offering

Getty Realty (GTY) is back in the spotlight after completing a follow on equity offering of 4,000,000 common shares at US$32.48 per share, raising about US$129.92 million in conjunction with related forward sale agreements. See our latest analysis for Getty Realty. The follow on offering comes after a run of solid reported results and a strong share price trend. Getty Realty’s 30 day share price return of 11.95% and year to date share price return of 18.32% sit alongside a 5 year total...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Is It Time To Reassess Tandem Diabetes Care (TNDM) After The Recent 43% Price Jump

If you are wondering whether Tandem Diabetes Care at around US$26.90 is starting to look mispriced, you are not alone. The numbers give us plenty to unpack. The stock has seen sharp recent moves, with a 42.8% return over the last 7 days and 35.2% over the last 30 days. This is even though the 1 year return sits at a 19.3% decline and the 5 year return at a 71.2% decline. Recent news coverage has focused on Tandem Diabetes Care's position in diabetes technology and product updates that keep...
NYSE:DDS
NYSE:DDSMultiline Retail

Dillard's (DDS) Solid 8.7% Net Margin Challenges Bearish Department Store Narratives

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...
NYSE:RKT
NYSE:RKTDiversified Financial

What Rocket Companies (RKT)'s Options Frenzy Around Earnings Means For Shareholders

In recent days, Rocket Companies has drawn increased attention as options markets price in very large potential stock moves ahead of its February 26, 2026 earnings release, amid elevated implied volatility and an extremely low put/call ratio that highlights heavily skewed positioning. This heightened speculation comes as Rocket advances its plan to become the largest U.S. mortgage servicer through the acquisition of Mr. Cooper Group, underlining how investors are weighing both...
NYSE:COHR
NYSE:COHRElectronic

A Look At Coherent (COHR) Valuation After A Sharp Share Price Rally

Why Coherent’s recent performance is on investors’ radar Coherent (COHR) has moved sharply in recent months, with the share price up 29% over the past month and 65% in the past 3 months, drawing fresh attention from growth-focused investors. See our latest analysis for Coherent. That recent surge sits on top of a strong run, with Coherent’s 1-year total shareholder return very large and its 3-year total shareholder return close to 5x, suggesting momentum has been building rather than...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Margin Reset From 15.9% To 9.1% Tests Bullish Narratives

Constellation Energy (CEG) has wrapped up FY 2025 with Q4 revenue of US$6.1b, Basic EPS of US$1.38 and net income of US$432m, putting a concrete set of numbers behind the recent share price of US$312.64. The company has seen quarterly revenue range between US$6.1b and US$6.8b across FY 2025, while Basic EPS moved from US$0.38 in Q1 to US$2.97 in Q3 before landing at US$1.38 in Q4, giving investors a clear view of how profit per share has shifted through the year. With trailing 12 month net...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Is It Too Late To Consider Sandisk (SNDK) After A 12x One-Year Surge?

If you are wondering whether Sandisk's current share price still reflects good value, you are not alone. The past year has put the stock firmly on many investors' watchlists. Sandisk last closed at US$638.52, with returns of 8.1% over 7 days, 34.8% over 30 days, 132.0% year to date, and a very large gain over the past year that is more than 12x. Recent coverage has focused on Sandisk as part of the broader interest in established US tech names. Investors are paying closer attention to how...
NYSE:TEX
NYSE:TEXMachinery

A Look At Terex (TEX) Valuation After A Strong Multi Period Share Price Run

Terex stock performance at a glance Terex (TEX) has drawn fresh attention after a strong recent run, with the share price showing a 15.5% gain over the past month and a 50.4% return over the past 3 months. For investors tracking longer horizons, Terex shows a 65.4% total return over the past year and 70.5% over five years, alongside annual revenue of US$5.4b and net income of US$221.0m. See our latest analysis for Terex. With the share price at US$68.85, Terex has moved from a softer 7 day...
NYSE:DECK
NYSE:DECKLuxury

Does Deckers’ Q3 Beat and Steady Outlook Recast the Bull Case For Deckers Outdoor (DECK)?

Deckers Outdoor recently reported Q3 2026 results that beat analyst expectations, with revenue rising year over year and full-year guidance reaffirmed. This performance, alongside upbeat analyst commentary on the resilience of UGG and HOKA and the company’s margin profile, has reinforced confidence in Deckers’ business momentum. Now we’ll examine how this earnings beat and renewed analyst confidence might reshape Deckers Outdoor’s existing investment narrative. We've uncovered the 16...
NYSE:BOH
NYSE:BOHBanks

Bank Of Hawaii CEO Exit And Insider Sale Focus Attention On Outlook

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...
NYSE:ETN
NYSE:ETNElectrical

Should Data Center Tailwinds and Insider Selling Shift How Investors View Eaton’s (ETN) Risk-Reward Balance?

In its fourth-quarter 2025 investor letter, RS Investments highlighted Eaton as benefiting from strong demand for data centers and electric grid upgrades, which have supported higher margins and improved returns on invested capital. At the same time, differing analyst opinions and increased insider selling, including share sales by Eaton’s CEO, add nuance to the otherwise constructive demand narrative around electrification and AI infrastructure. Next, we’ll examine how this emphasis on...
NasdaqGS:CAR
NasdaqGS:CARTransportation

A Look At Avis Budget Group (CAR) Valuation After Recent Share Price Weakness

Recent price moves and earnings snapshot Avis Budget Group (CAR) has been under pressure recently, with the stock showing a 23% decline over the past month and close to 30% over the past 3 months, catching the attention of value focused investors. The company reports annual revenue of US$11.65b and a net loss of US$889 million, giving investors a mix of sizeable scale and recent earnings pressure to weigh against its current share price of US$93.99. See our latest analysis for Avis Budget...
NYSE:PAG
NYSE:PAGSpecialty Retail

Is It Time To Reassess Penske Automotive Group (PAG) After Recent Share Price Cooldown?

If you are wondering whether Penske Automotive Group at around US$161.81 is offering good value today, you are not alone. Many investors are asking the same question as the stock cools off from past gains. Over shorter periods the picture is mixed, with a 2.3% decline over the last week, a 1.5% gain over 30 days and a 2.3% return year to date. The 3 year and 5 year returns sit at 21.6% and 161.1% respectively, and the 1 year return is roughly flat at a 0.2% decline. Recent coverage has...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

A Look At PROCEPT BioRobotics (PRCT) Valuation As Investors Await Rescheduled Earnings Call And Investor Day

PROCEPT BioRobotics (PRCT) is back in focus after rescheduling its fourth quarter 2025 earnings call and in person Investor Day, with investors watching for fresh guidance and multi year targets under new CEO Larry Wood. See our latest analysis for PROCEPT BioRobotics. At a share price of $27.26, PROCEPT BioRobotics has seen weaker momentum recently, with a 30 day share price return of a 6.42% decline and a 1 year total shareholder return of a 56.53% loss. This helps explain why the...
NYSE:YSS
NYSE:YSSAerospace & Defense

Is York Space Systems (YSS) Offering Value After A 16.8% Year To Date Share Price Drop

If you are wondering whether York Space Systems at around US$27.95 is offering good value today, this article walks through what the numbers actually say about the stock. The share price has been relatively steady over the past week with a 0.2% decline, but year to date the stock is down 16.8%. This may change how you think about its risk and potential. Recent coverage has focused on York Space Systems as a listed space infrastructure player, highlighting investor interest in satellite...
NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

Vaxcyte Advances VAX 31 To Late Stage With Added Pipeline Potential

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...
NasdaqGS:HTZ
NasdaqGS:HTZTransportation

Assessing Hertz Global Holdings (HTZ) Valuation After Recent Share Price Volatility

Hertz Global Holdings (HTZ) has been on many investors’ watchlists after a mixed share price pattern, with a roughly 20% decline over the past month but a modest gain over the past year. See our latest analysis for Hertz Global Holdings. With the latest share price at $4.44, Hertz Global Holdings has seen momentum fade recently, with a 30-day share price return of 19.71% and a year-to-date share price return of 14.94%, even though the 1-year total shareholder return is 4.72% and the 3-year...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

A Look At Hologic (HOLX) Valuation As Shares Reenter Investor Focus

Why Hologic Stock Is Back on Investors’ Radar Hologic (HOLX) is drawing fresh attention after recent share price moves, prompting investors to reassess how its current valuation lines up with the company’s fundamentals and recent share performance. The stock last closed at US$75.35, with total return readings ranging from a small 1 day decline to a modest gain over the past 3 months and a stronger move over the past year. See our latest analysis for Hologic. For Hologic, a 1 year total...
NYSE:LYV
NYSE:LYVEntertainment

Is Live Nation Entertainment (LYV) Fairly Priced After Ongoing Ticketing Regulation Scrutiny?

If you are wondering whether Live Nation Entertainment's current share price lines up with its underlying value, you are not alone. Many investors are asking the same question right now. The stock last closed at US$157.98, with returns of 0.3% over the past week, 7.5% over the past month, 8.7% year to date and 9.4% over the past year, so it is understandable that investors want to know what is priced in. Recent headlines around Live Nation have continued to focus on the broader live events...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Assessing LivaNova (LIVN) Valuation After 2025 Results 2026 Outlook And Orrum Data Partnership

Fourth quarter earnings and 2026 outlook LivaNova (NasdaqGS:LIVN) reported fourth quarter and full year 2025 results, paired with 2026 guidance and a new data partnership, giving investors fresh information on both financial performance and product ecosystem development. For the fourth quarter, LivaNova reported sales of US$360.9 million, compared with US$321.8 million a year earlier. Net income for the period was US$30.9 million, versus US$55.9 million in the prior year quarter. Basic...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Freshpet (FRPT) Valuation Check After Mixed Share Performance Signals And Conflicting Fair Value Estimates

What recent performance tells you about Freshpet (FRPT) Freshpet (FRPT) has drawn investor attention after a period of mixed share performance, with a return of 12.9% over the past month and 43.8% over the past 3 months, alongside a 24.4% decline over the past year. See our latest analysis for Freshpet. Freshpet’s recent 7 day share price return of 12.8% and 90 day share price return of 43.8% contrast with a 1 year total shareholder return decline of 24.4%. This suggests near term momentum is...
NYSE:TKR
NYSE:TKRMachinery

A Look At Timken (TKR) Valuation After New Buyback Plan And Dividend Confirmation

Why Timken’s latest capital moves are on investors’ radar Timken (TKR) is back in focus after its board signed off on a share repurchase program covering up to 10,000,000 shares, paired with an affirmed quarterly dividend and fresh M&A commentary from management. See our latest analysis for Timken. That capital plan comes on the heels of a sharp upswing in the share price, with a 16.6% 1 month share price return and 34.6% 3 month share price return. The 1 year total shareholder return of...